Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2011 4
2012 1
2014 1
2017 1
2018 1
2019 4
2020 8
2021 12
2022 9
2023 11
2024 18
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Authors' reply.
Silvestre Salvador JF, Giménez-Arnau AM, Gómez de la Fuente E, González Del Castillo J, Martínez Virto AM, Miguens Blanco I, Serra-Baldrich E, Llorens P. Silvestre Salvador JF, et al. Among authors: gimenez arnau am. Emergencias. 2021 Aug;33(4):325-326. Emergencias. 2021. PMID: 34251150 Free article. English, Spanish. No abstract available.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Among authors: gimenez arnau am. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Biological drugs for the treatment of children with chronic spontaneous urticaria.
Podder I, Salman A, Asero R, Teresa Caballero M, Caffarelli C, De Las Vecillas L, Gimenez-Arnau AM, Giovannini M, Kocatürk E, Kolkhir P, Manti S, Navarro Cascales T, Maurer M. Podder I, et al. Among authors: gimenez arnau am. Expert Rev Clin Immunol. 2024 Dec;20(12):1427-1435. doi: 10.1080/1744666X.2024.2388689. Epub 2024 Nov 18. Expert Rev Clin Immunol. 2024. PMID: 39555837 Review.
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study.
Kocatürk E, Salameh P, Sarac E, Vera Ayala CE, Thomsen SF, Zuberbier T, Ensina LF, Popov TA, van Doorn MBA, Giménez-Arnau AM, Asero R, Criado PR, Aarestrup FM, AbdulHameed Ansari Z, Al Abri S, Al-Ahmad M, Al Hinai B, Allenova A, Al-Nesf M, Altrichter S, Arnaout R, Bartosińska J, Bauer A, Bernstein JA, Bizjak M, Bonnekoh H, Bouillet L, Brzoza Z, Calvalcanti Dela Bianca Melo AC, Campinhos FL, Carne E, Purayil SC, Cherrez-Ojeda I, Chong-Neto HJ, Christoff G, Conlon N, Jardim Criado RF, Cvenkel K, Damadoglu E, Danilycheva I, Day C, de Montjoye L, Demir S, Ferucci SM, Fomina D, Fukunaga A, Garcia E, Gelincik A, Göbel JH, Godse K, Gonçalo M, Gotua M, Grattan C, Gugala A, Guillet C, Kalyoncu AF, Karakaya G, Kasperska-Zając A, Katelaris CH, Khoshkhui M, Kleinheinz A, Kolacinska-Flont M, Kolkhir P, Košnik M, Krasowska D, Kumaran MS, Kuprys-Lipinska I, Kurowski M, Kuznetsova EV, Larenas-Linnemann D, Lebedkina MS, Lee Y, Makris M, Gómez RM, Nasr I, Neisinger S, Oda Y, Kara RÖ, Palitot EB, Papapostolou N, Salvador Parisi CA, Pesque D, Peter J, Petkova E, Ridge K, Rudenko M, Rutkowski K, Saini SS, Salman A, Sanchez J, Şekerel B, Serdotetskova SA, Serpa FS, Dikicier BS, Sidiropoulos N, S… See abstract for full author list ➔ Kocatürk E, et al. Among authors: gimenez arnau am. J Allergy Clin Immunol. 2023 Nov;152(5):1095-1106. doi: 10.1016/j.jaci.2023.07.019. Epub 2023 Aug 12. J Allergy Clin Immunol. 2023. PMID: 37574079
Current frequency of contact allergy to isothiazolinones (methyl-, benz- and octylisothiazolinone) across Europe.
Schwensen JFB, Uter W, Aerts O, Agner T, Brans R, Bruze M, Foti C, Giménez-Arnau AM, Gonçalo M, Svedman C, Stingeni L, Wilkinson M, Johansen JD; European Environmental Contact Dermatitis Research Group. Schwensen JFB, et al. Among authors: gimenez arnau am. Contact Dermatitis. 2024 Oct;91(4):271-277. doi: 10.1111/cod.14641. Epub 2024 Jul 17. Contact Dermatitis. 2024. PMID: 39021255
Contact Urticaria and Related Conditions: Clinical Review.
Bizjak M, Aerts O, Pesqué D, Muñoz M, Asero R, Gonçalo M, Rustemeyer T, Košnik M, Kačar M, Goossens A, Alfonso JH, Mortz CG, Al-Nesf MA, Fluhr JW, Maibach HI, Giménez-Arnau AM. Bizjak M, et al. Among authors: gimenez arnau am. Contact Dermatitis. 2025 Apr 2. doi: 10.1111/cod.14794. Online ahead of print. Contact Dermatitis. 2025. PMID: 40174899 Review.
69 results